The estrogen receptor (ER) is expressed in the majority of breast tumors and in a number of endocrine tissues including the normal breast, uterus, and vagina, as well as in the pituitary and hypothalamus. Fulvestrant is the first of a new type of endocrine treatment——an oestrogen receptor (ER) antagonist...